Drug Discovery and Development

Drug discovery is a process which is intended to identify a small synthetic molecule or a large biomolecule for comprehensive evaluation as a potential drug candidate. Broadly, the modern drug discovery process includes identification of disease to be treated and its unmet medical need, selection of a druggable molecular target and its validation, in vitro assay development followed by high throughput screening of compound libraries against the target to identify hits, and hit optimization to generate lead compounds that exhibit adequate potency and selectivity towards the biological target in vitro and which demonstrate efficacy in animal models of disease. Subsequently, the lead compounds are further optimized to improve their efficacy and pharmacokinetics before they advance towards drug development.

Drug development process can be segregated into preclinical and clinical development stages. In preclinical development, toxicological and safety pharmacology studies of the candidate are conducted in order to establish the maximum safe concentrations in animals and determine the adverse effect potential of the drug-in-development. Additionally, studies are conducted to finalize cost-effective processes required for manufacturing the candidate drug as well as deciding on its best formulation. If the candidate exhibits sufficient efficacy and safety in preclinical evaluation, permission is sought from drug regulatory agencies to initiate its clinical development wherein the safety and efficacy of the drug candidate is assessed in pilot and pivotal studies.

 

  • Computational approaches in drug discovery and precision medicine
  • Phosphonate chemistry in drug design and development
  • In silico methods for drug design and discovery
  • Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
  • Anti-Tubercular drugs
  • Computational drug discovery for targeting of protein-protein interfaces
  • Multi-target-directed ligands (MTDL) in drug discovery: from design to pharmacological evaluation

Related Conference of Drug Discovery and Development

November 25-26, 2024

19th Annual Congress on Neuroscience

Paris, France
November 26-27, 2024

4th Annual Dementia Congress

Paris, France
December 05-06, 2024

7th World Congress on Epilepsy and Brain Disorders

Dubai, UAE
December 05-06, 2024

9th Annual Congress on Pediatric Neurology and Pediatric Surgery

Prague, Czech Republic
December 11-12, 2024

9th World Congress on Spine and Spinal Disorders

Paris, France
December 12-13, 2024

36th World Congress on Neurorehabilitation

London, UK
December 12-13, 2024

38th European Neurology Congress

Rome, Italy
February 03-04, 2025

37th World Conference on Neurology

London, UK
February 17-18, 2025

5th International Conference on Child Neurology

Aix-en-Provence, France
February 20-21, 2025

6th International Conference on Neurologists

Amsterdam, Netherlands
February 24-25, 2025

4th International Conference onAlzheimer and Dementia

Madrid, Spain
February 27-28, 2025

7th World Depression Congress

Paris, France
March 10-11, 2025

8th World Conference on Neuroscience

Paris, France
March 13-14, 2025

7th World Conference on Neuroscience

Prague, Czech Republic
March 24-25, 2025

38th European Neurology Congress 2025

London, UK
April 24-25, 2025

6th World Congress on Sleep Disorders and Therapeutics

Amsterdam, Netherlands
April 29-30, 2025

11th International Conference on Epilepsy & Treatment

Barcelona, Spain
July 17-18, 2025

31st Annual Summit on Neuroscience & Neurological Disorders

Amsterdam, Netherlands
July 17-18, 2025

35th World Congress on Neurology and Neuroscience

Aix-en-Provence, France
July 23-24, 2025

15th Global Alzheimers Summit

Paris, France

Drug Discovery and Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in